Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement
Recruiting now · Not applicable
Conditions studied: Sinus Lifting
In brief
Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma. Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla. Methods: This study will be carried out as a randomized
Key facts
- Study ID
- NCT07150858
- Run by
- Alexandria University
- People needed
- 20
- Starts
- 2025-05-25
- Expected to finish
- 2026-07-25
- Last updated by the study team
- 2025-09-02
Who can join
Age: 20 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Residual bone height not less than 5 mm measured from crestal bone to sinus floor.
- Both genders.
- Good oral hygiene
- No previous surgery or radiation treatment on the maxillary sinus
You may not qualify if…
- Recent radiation therapy in maxilla.
- Uncontrolled systemic diseases such as diabetes mellitus.
- Heavy smoker (those who smoke ≥ 25 cigarettes a day).
- Alcohol abuse.
- Patient on anticoagulant drug
- Severe allergic rhinitis.
- Tumor or large cyst in the maxillary sinus.
- Oroantral fistula.
- Presence of acute or chronic sinus pathoses or sinus membrane perforation.(
Where it is running
- Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University — Alexandria, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.